US grant · Terrin Brown Grantor
Minor Use Minor Species Development of Drugs (R01)
Up to $250,000 Closes January 29, 2027
Official listing and how to apply Full funding notice
Source: Grants.gov · Last checked
Key facts
| Funder | Terrin Brown Grantor |
|---|---|
| Part of | Department of Health and Human Services |
| Opportunity number | PAR-24-216 |
| Amount per award | Up to $250,000 |
| Total funding available | $250,000 |
| Opens | May 29, 2024 |
| Closes | January 29, 2027 (80 days left) |
| Who can apply | Schools and universities, Businesses, Government, Nonprofits, Other (see listing), Tribal organizations |
| Applicant types listed | Public and State controlled institutions of higher education; County governments; Native American tribal governments (Federally recognized); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Independent school districts; Special district governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; Small businesses; State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; Public housing authorities/Indian housing authorities; Native American tribal organizations (other than Federally recognized tribal governments) |
| State or area | Nationwide |
| Cost sharing or match | Not required |
| Application detail | Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027 |
| Status | Open |
| Source | Grants.gov |
| Last checked | November 10, 2026 |
About this grant
Summary from the official listing on Grants.gov:
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS).
The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.
Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.
The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.
FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.
Eligibility
• Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)
Details are copied from the official source and can change. Check the official listing before you apply. Grant Writing Company is not affiliated with this funder.
Want an expert to write it with you?
Grant Writing Company researches funders, writes organization proposals to each funder's instructions, and checks the package before you submit. experience since 2006. Funders decide every award.